Benchmark Capital Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $764K | Hold |
|
|||||
|
2018
Q3 | $1.34M | Buy |
|
|||||
|
2018
Q2 | $1.41M | Hold |
|
|||||
|
2018
Q1 | $1.05M | Buy |
|
|||||
|
2017
Q4 | $619K | Sell |
|
|||||
|
2017
Q3 | $416K | Hold |
|
|||||
|
2017
Q2 | $478K | Hold |
|
|||||
|
2017
Q1 | $447K | Sell |
|
|||||
|
2016
Q4 | $194K | Buy |
|
|||||
|
2016
Q3 | $134K | Buy |
|
|||||
|
2016
Q2 | $88K | Hold |
|
|||||
|
2016
Q1 | $85K | Hold |
|
|||||
|
2015
Q4 | $98K | Sell |
|
|||||
|
2015
Q3 | $163K | Sell |
|
|||||
|
2015
Q2 | $195K | Sell |
|
|||||
|
2015
Q1 | $334K | Sell |
|
|||||
|
2014
Q4 | $347K | Sell |
|
|||||
|
2014
Q3 | $672K | Buy |
|
|||||
|
2014
Q2 | $1.23M | Buy |
|
|||||
|
2014
Q1 | $1.3M | Hold |
|
|||||
|
2013
Q4 | $687K | Buy |
|
|||||
|
2013
Q3 | $653K | Buy |
|
|||||
|
2013
Q2 | $85K | Buy |
|